Adalimumab Efficacy in Patients with Psoriasis Who Received or Did Not Respond to Prior Systemic Therapy: A Pooled Post Hoc Analysis of Results from Three Double-Blind, Placebo-Controlled Clinical Trials
Crossref DOI link: https://doi.org/10.1007/s40257-015-0161-5
Published Online: 2015-11-07
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Papp, Kim A.
Armstrong, April W.
Reich, Kristian
Karunaratne, Mahinda
Valdecantos, Wendell
Funding for this research was provided by:
AbbVie (US)
License valid from 2015-11-07